Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

HeartSciences (HSCS) Return on Equity (2022 - 2026)

HeartSciences' Return on Equity history spans 5 years, with the latest figure at 2.49% for Q1 2026.

  • For Q1 2026, Return on Equity rose 49.0% year-over-year to 2.49%; the TTM value through Jan 2026 reached 2.49%, up 49.0%, while the annual FY2025 figure was 2.35%, 59.0% down from the prior year.
  • Return on Equity reached 2.49% in Q1 2026 per HSCS's latest filing, down from 2.48% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 462.32% in Q2 2023 to a low of 16.36% in Q1 2023.
  • Average Return on Equity over 5 years is 29.24%, with a median of 1.69% recorded in 2024.
  • Peak YoY movement for Return on Equity: skyrocketed 46132bps in 2023, then tumbled -46315bps in 2024.
  • A 5-year view of Return on Equity shows it stood at 3.36% in 2022, then surged by 266bps to 5.58% in 2023, then crashed by -128bps to 1.56% in 2024, then tumbled by -59bps to 2.48% in 2025, then dropped by -1bps to 2.49% in 2026.
  • Per Business Quant, the three most recent readings for HSCS's Return on Equity are 2.49% (Q1 2026), 2.48% (Q4 2025), and 5.27% (Q3 2025).